2026 Global: Cellulite Treatment-Competitive Review (2032) report
Description
The 2026 Global: Cellulite Treatment-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cellulite treatment by geography and historical trend. The scope of the report extends to sizing of the cellulite treatment market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The cellulite treatment market features leading companies specializing in non-invasive, minimally invasive, and topical solutions, driven by innovations like radiofrequency, laser therapies, and injectables. Top ten major players include Merz Pharma, renowned for Cellfina, a minimally invasive subcision treatment with proven five-year efficacy on thighs and buttocks; Hologic Inc. (Cynosure), dominant in laser and ultrasound devices for skin tightening and fat reduction; Syneron Medical (Candela Syneron), offering advanced radiofrequency and optical energy systems for collagen stimulation; Zimmer Aesthetics, providing cryolipolysis and mechanical massage technologies for circulation enhancement; and Alma Lasers, excelling in dynamic cooling and fractional lasers for cellulite reduction. These firms hold significant shares through R&D investments and partnerships, with North America leading at 38.8% market dominance due to high adoption.
Complementing these are Lumenis, a pioneer in energy-based devices like ultrapulsed lasers targeting fibrous septae; BTL Industries, leveraging high-intensity electromagnetic energy combined with radiofrequency for muscle toning and cellulite smoothing in 30-minute sessions; Cutera Inc., known for vascular and pigment lasers adapted for edematous cellulite; Cymedics, focusing on acoustic wave therapy for lymphatic drainage and skin elasticity; and Nubway (Beijing Nubway S&T), delivering affordable cavitation and RF systems popular in Asia-Pacific growth markets. Merz and Hologic command substantial portions via FDA-approved products like Qwo injectables from Revance (now integrated strategies) and TempSure RF platforms. Clinic dominance at 58.1% end-user share amplifies their reach, as non-invasive procedures capture 52.3% revenue.
Market leaders innovate amid 10.6% CAGR projections to $6.8 billion by 2034, addressing soft cellulite (48% share) through personalized, low-downtime options. AbbVie enters via acquisitions enhancing filler synergies, while Endo International disrupted with enzymatic Qwo for fibrous band lysis. Strategic mergers, like Candela-Mez, expand portfolios globally. Challenges persist in temporary results, yet AI-driven protocols and subscription models from Venus Concept bolster loyalty. Asia-Pacific surges via infrastructure upgrades, positioning Nubway strongly. Overall, these ten—Merz, Hologic/Cynosure, Syneron/Candela, Zimmer, Alma, Lumenis, BTL, Cutera, Cymedics, Nubway—drive 40%+ combined share through tech convergence and consumer demand for aesthetic enhancements. (448 words)
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cellulite treatment by geography and historical trend. The scope of the report extends to sizing of the cellulite treatment market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The cellulite treatment market features leading companies specializing in non-invasive, minimally invasive, and topical solutions, driven by innovations like radiofrequency, laser therapies, and injectables. Top ten major players include Merz Pharma, renowned for Cellfina, a minimally invasive subcision treatment with proven five-year efficacy on thighs and buttocks; Hologic Inc. (Cynosure), dominant in laser and ultrasound devices for skin tightening and fat reduction; Syneron Medical (Candela Syneron), offering advanced radiofrequency and optical energy systems for collagen stimulation; Zimmer Aesthetics, providing cryolipolysis and mechanical massage technologies for circulation enhancement; and Alma Lasers, excelling in dynamic cooling and fractional lasers for cellulite reduction. These firms hold significant shares through R&D investments and partnerships, with North America leading at 38.8% market dominance due to high adoption.
Complementing these are Lumenis, a pioneer in energy-based devices like ultrapulsed lasers targeting fibrous septae; BTL Industries, leveraging high-intensity electromagnetic energy combined with radiofrequency for muscle toning and cellulite smoothing in 30-minute sessions; Cutera Inc., known for vascular and pigment lasers adapted for edematous cellulite; Cymedics, focusing on acoustic wave therapy for lymphatic drainage and skin elasticity; and Nubway (Beijing Nubway S&T), delivering affordable cavitation and RF systems popular in Asia-Pacific growth markets. Merz and Hologic command substantial portions via FDA-approved products like Qwo injectables from Revance (now integrated strategies) and TempSure RF platforms. Clinic dominance at 58.1% end-user share amplifies their reach, as non-invasive procedures capture 52.3% revenue.
Market leaders innovate amid 10.6% CAGR projections to $6.8 billion by 2034, addressing soft cellulite (48% share) through personalized, low-downtime options. AbbVie enters via acquisitions enhancing filler synergies, while Endo International disrupted with enzymatic Qwo for fibrous band lysis. Strategic mergers, like Candela-Mez, expand portfolios globally. Challenges persist in temporary results, yet AI-driven protocols and subscription models from Venus Concept bolster loyalty. Asia-Pacific surges via infrastructure upgrades, positioning Nubway strongly. Overall, these ten—Merz, Hologic/Cynosure, Syneron/Candela, Zimmer, Alma, Lumenis, BTL, Cutera, Cymedics, Nubway—drive 40%+ combined share through tech convergence and consumer demand for aesthetic enhancements. (448 words)
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.